Liming Shao

USPTO Granted Patents = 38 (Patent Applications = 5)

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 237(Granted Patents)

Company Filing History:

21 out of 130

Sunovion Pharmaceuticals Inc.

Pgi Drug Discovery LLC

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

38 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11332462 - Heteroaryl compounds and methods of use thereof (2022-05-17),

2. 10894033 - Multicyclic compounds and methods of use thereof (2021-01-19),

3. 10562878 - Cycloalkylamines as monoamine reuptake inhibitors (2020-02-18),

4. 10556890 - Heteroaryl compounds and methods of use thereof (2020-02-11),

5. 10428021 - Triple reuptake inhibitors and methods of their use (2019-10-01),

6. 10189825 - Heteroaryl compounds and methods of use thereof (2019-01-29),

7. 10085968 - Multicyclic compounds and methods of use thereof (2018-10-02),

8. 9868718 - Cycloalkylamines as monoamine reuptake inhibitors (2018-01-16),

9. 9850204 - Triple reuptake inhibitors and methods of their use (2017-12-26),

10. 9586888 - Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors (2017-03-07),

11. 9505716 - Pyrrolidine triple reuptake inhibitors (2016-11-29),

12. 9351954 - Multicyclic compounds and methods of use thereof (2016-05-31),

13. 9133117 - Triple reuptake inhibitors and methods of their use (2015-09-15),

14. 9056830 - Pyrrolidine triple reuptake inhibitors (2015-06-16),

15. 8877975 - Cycloalkylamines as monoamine reuptake inhibitors (2014-11-04),

Certainly! Here is an article about the inventor Liming Shao:

Title: A Glimpse into Inventor Liming Shao's Innovations in Neurological Disorders

Introduction:

In the realm of pharmaceuticals and neurological disorders, Inventor Liming Shao has made significant strides in innovation. With a location in Lincoln, MA (US), Liming Shao showcases a remarkable portfolio of 38 patents, focusing on advancements in treating psychosis, schizophrenia, and other neurological conditions.

Latest Patents:

Liming Shao's latest patents include groundbreaking inventions such as "Heteroaryl Compounds and Methods of Use Thereof" and "Multicyclic Compounds and Methods of Use Thereof." These patents introduce novel thiophene and multicyclic compounds, along with methods of synthesis, pharmaceutical compositions, and applications for treating various neurological disorders.

Career Highlights:

Liming Shao's expertise has been instrumental in companies like Sunovion Pharmaceuticals Inc. and Sepracor, Inc., where he has contributed significantly to research and development in the pharmaceutical industry. His innovative approach and dedication have propelled advancements in the treatment and management of neurological disorders.

Collaborations:

Throughout his career, Liming Shao has collaborated with accomplished professionals in the field, including Fengjiang Wang and Brian M. Aquila. Together, they have synergized their expertise to drive forward cutting-edge solutions for addressing complex neurological challenges.

Conclusion:

In conclusion, Liming Shao stands as a pioneering inventor in the realm of pharmaceuticals, particularly in the treatment of neurological disorders. With a rich tapestry of patents and collaborations, his contributions continue to make a profound impact on the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.